Subsequent Neoplasia in Chronic Lymphocytic Leukemia

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 1975 Apr 21

PMID 47401

Citations 38

Authors

D Manusow

B H Weinerman

Affiliations

Soon will be listed here.

Abstract

We performed a retrospective analysis of all 102 cases of chronic lymphocytic leukemia (CLL) treated by the Hematology Service of the University of Manitoba from Jan 1, 1955, to April 1, 1974. The incidence of secondary cancer was compared with that in the Cancer Registry population of Manitoba of the same age and sex distribution. The risk of all cancers developing in patients with CLL was threefold that for the age- and sex-matched population, eightfold for skin cancers, and twofold for all cancers excluding skin cancer.

Citing Articles

The Immune Microenvironment in Basal Cell Carcinoma.

Zilberg C, Lyons J, Gupta R, Damian D Ann Dermatol. 2023; 35(4):243-255.

PMID: 37550225 PMC: 10407341. DOI: 10.5021/ad.22.042.

Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study.

Sayin S, Kiliacslan E, Yildirim M, Afacan Ozturk H, Safak Yilmaz E, Albayrak M Asian Pac J Cancer Prev. 2023; 24(6):1971-1977.

PMID: 37378926 PMC: 10505873. DOI: 10.31557/APJCP.2023.24.6.1971.

Neoplastic and Autoimmune Comorbidities in Patients with Primary Cutaneous B-Cell Lymphoma.

Mazzetto R, Tartaglia J, Sernicola A, Alaibac M Hematol Rep. 2023; 15(1):157-165.

PMID: 36975729 PMC: 10048514. DOI: 10.3390/hematolrep15010016.

Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome.

Shen Y, Coyle L, Kerridge I, Stevenson W, Arthur C, McKinlay N EJHaem. 2022; 3(1):129-138.

PMID: 35846218 PMC: 9175984. DOI: 10.1002/jha2.366.

Synchronous oral squamous cell carcinoma and a lymphoproliferative disorder in an adult: a challenge in diagnosis and management.

Van der Groen T, Shupak R, Kim R BMJ Case Rep. 2022; 15(2).

PMID: 35135796 PMC: 8830111. DOI: 10.1136/bcr-2021-246641.